Rapid Microbiology Testing Market Forecasts to 2030 – Global Analysis By Product (Instruments, Reagents and kits, Consumables and Other Products), Method, Application and By Geography

Rapid Microbiology Testing Market Forecasts to 2030 – Global Analysis By Product (Instruments, Reagents and kits, Consumables and Other Products), Method, Application and By Geography

According to Stratistics MRC, the Global Rapid Microbiology Testing Market is accounted for $4.7 billion in 2023 and is expected to reach $9.7 billion by 2030 growing at a CAGR of 10.8% during the forecast period. Microbiology testing is done quickly to identify potential health threats from microorganisms early on, monitor vital control points in real time, optimize production processes, boost product safety, and lower overall quality procedure costs. Rapid microbiological testing is a technology used in drug development, research, and other diagnostic applications. Rapid microbiological testing is used to help diagnose infections like TB and malaria quickly. This aids in the treatment of lower respiratory tract infections. When compared to conventional testing based on culture, these tests yield speedier findings.

According to the PHAC, there were over 225,000 reported cases of notifiable infectious diseases in Canada in 2021, including sexually transmitted infections, foodborne illnesses, and respiratory infections.

Market Dynamics:

Driver:

Rising rates of infectious illnesses

Infectious illnesses including malaria, HIV, pneumonia, and TB are becoming more common. Programs to raise awareness of infectious diseases including HIV, cancer, TB, and pneumonia have become more prevalent in an effort to promote early detection and preventative healthcare, which can lead to better treatment outcomes. The increased global burden of these disorders will probably result in a significant rise in demand for fast microbiological procedures throughout the forecast period.

Restraint:

Inadequate healthcare services

Many individuals in underdeveloped nations lack access to healthcare facilities and the necessary information to maintain their health. Additionally, a major barrier to public health is a lack of funding, which exacerbates the problem of infectious illnesses, which is a serious public health concern. Furthermore, the majority of poor nations' healthcare systems struggle to staff with qualified professionals, which makes it challenging for them to offer access to high-quality medical services like quick microbiological testing. This reflects the impediment to the market's expansion.

Opportunity:

Increasing concerns about food safety

Food items consist of both plants and animals, and they typically include a range of microbes. During the production and consumption stages, food may come into touch with natural source microbes and get contaminated. To guarantee that the food and beverage sectors provide customers with the highest level of product safety and quality, regulatory bodies regularly update food safety laws. As a result, growth in the market is anticipated throughout the forecast period.

Threat:

High equipment cost

Rapid procedures may incur greater initial setup expenses for equipment compared to older approaches. For smaller labs or institutions with tighter funds, this might be a hindrance. Test kits and cartridges, among other consumables used in quick techniques, can be costly. These expenses have the potential to accumulate over time and eventually outweigh those related to conventional techniques. These are the things impeding the market's expansion.

Covid-19 Impact:

At the early phase of pandemic, there was no availability of specific diagnostic tests to detect the disease in patients. Alternative diagnostic tests were used initially but were not much effective. This unavailability of specific COVID-19 diagnostic tests presented lucrative opportunities for diagnostic manufacturers to introduce their diagnostic kits. Many leading players as well as some start-ups from various countries utilized this opportunity and introduced diagnostics kits into local as well as global market. These players achieved edge over other diagnostics players capitalizing the opportunity from demand for diagnostic tests, which, in turn, helps them in maintaining their revenues in such a crisis.

The cellular component based segment is expected to be the largest during the forecast period

The cellular component based segment is expected to be the largest during the forecast period, owing to more accurate and more sensitive detection of microbial pathogens, which is crucial for effective treatment and control of infectious diseases. Rapid microbiological testing based on cellular components is used to diagnose a number of serious conditions, such as foodborne infections, infections linked to healthcare, and infectious diseases. The market is anticipated to keep expanding in the future due to the growing need for quicker and more precise diagnostic tests for these illnesses.

The clinical diagnosis testing segment is expected to have the highest CAGR during the forecast period

The clinical diagnosis testing segment is expected to have the highest CAGR during the forecast period. In order to identify and categorize infectious bacteria in clinical samples including blood, urine, and sputum, rapid microbiology testing methods are employed in clinical diagnosis. Rapid microbiological testing methods are becoming more and more necessary in clinical settings as infectious illnesses become more common. Technological advancements in testing methodologies have improved testing accuracy and efficiency, hence encouraging their usage in clinical diagnostics across the industry.

Region with largest share:

North America is projected to hold the largest market share during the forecast period. The market is expanding due to a number of factors, including the increased emphasis on the creation of drugs and vaccines, recent developments in biotechnology and pharmaceutical research, and the availability of several vendors in the nation that provide a broad selection of microbial testing products. Thus, a key factor in the region's acceptance of microbiological testing has been the increased focus on medication manufacture.

Region with highest CAGR:

Asia Pacific is projected to hold the highest CAGR over the forecast period. The demand for quicker results in a variety of sectors, stricter laws, and a growing understanding of the significance of microbiological safety have all contributed to the growing acceptance of rapid microbiology testing procedures. The development of more quick and precise microbiological testing techniques is facilitated by ongoing technological improvements.

Key players in the market

Some of the key players in Rapid Microbiology Testing market include Thermo Fisher Scientific Inc., Don Whitley Scientific Limited, Mocon, Inc, Becton, Dickinson, and Company, Danaher Corporation, Merck KGaA, Rapid Micro Biosystems Inc., Vivione Biosciences LLC, Abbott Laboratories, Inc., Quidel Corporation, Sartorius AG, Biomerieux SA, NEOGEN Corporation and Microgenetics.

Key Developments:

In September 2022, Microgenetics developed a Rapid Microbial Method with a six-hour turnaround time. This crucial stage is costing many businesses time and resources because compendial methods of microbial contamination tests have a turnaround time of 14 days, and even faster technologies take about 4 days.

In August 2022, Together, BD and Accelerate Diagnostics are fighting antibiotic resistance. Through a global commercial partnership, BD will make available Accelerate’s rapid testing solution for antibiotic resistance and susceptibility, which provides results in hours as opposed to one to two days, as is the case with some conventional laboratory techniques.

Products Covered:
• Instruments
• Reagents and kits
• Consumables
• Other Products

Methods Covered:
• Viability Based
• Nucleic Acid Based
• Cellular Component Based
• Growth Based
• Other Methods

Applications Covered:
• Food and Beverage Testing
• Cosmetics and Personal Care Products Testing
• Pharmaceutical and Biological Drug Testing
• Clinical Disease Diagnosis Testing
• Environmental Testing
• Other Applications

Regions Covered:
• North America
US
Canada
Mexico
• Europe
Germany
UK
Italy
France
Spain
Rest of Europe
• Asia Pacific
Japan
China
India
Australia
New Zealand
South Korea
Rest of Asia Pacific
• South America
Argentina
Brazil
Chile
Rest of South America
• Middle East & Africa
Saudi Arabia
UAE
Qatar
South Africa
Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements